-
Symbol
-
CTOR on Nasdaq
-
Investment type
-
Equity / Common stock, $0.0001 par value
-
Latest Disclosed Ownership
-
66M shares
-
Security Ownership
-
79.1%
Citius Pharmaceuticals, Inc. ownership in CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR)
2025-09-12 - Citius Pharmaceuticals, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 66M shares of CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR).
This represents 79.1% percent ownership of the company.